INOMAX EVOLVE Trademark

Trademark Overview

On Thursday, March 2, 2023, a trademark application was filed for INOMAX EVOLVE with the United States Patent and Trademark Office. The USPTO has given the INOMAX EVOLVE trademark a serial number of 97820856. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, February 18, 2026. This trademark is owned by Mallinckrodt Pharmaceuticals Ireland Limited. The INOMAX EVOLVE trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients

General Information

Serial Number97820856
Word MarkINOMAX EVOLVE
Filing DateThursday, March 2, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, February 18, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements

Goods and ServicesMedical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, March 22, 2023
Primary Code010
First Use Anywhere DateThursday, February 29, 2024
First Use In Commerce DateThursday, February 29, 2024

Trademark Owner History

Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 15 D15TX2V
IE
Party NameMallinckrodt Pharmaceuticals Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 15 D15TX2V
IE

Trademark Events

Event DateEvent Description
Monday, March 6, 2023NEW APPLICATION ENTERED
Wednesday, March 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 13, 2023ASSIGNED TO EXAMINER
Friday, July 14, 2023NON-FINAL ACTION WRITTEN
Friday, July 14, 2023NON-FINAL ACTION E-MAILED
Friday, July 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 1, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 1, 2024SOU EXTENSION 1 FILED
Monday, July 1, 2024SOU EXTENSION 1 GRANTED
Monday, July 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 31, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 31, 2024SOU EXTENSION 2 FILED
Wednesday, January 1, 2025SOU EXTENSION 2 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 27, 2025SOU TEAS EXTENSION RECEIVED
Friday, June 27, 2025SOU EXTENSION 3 FILED
Friday, June 27, 2025SOU EXTENSION 3 GRANTED
Saturday, June 28, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 8, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, January 24, 2026ASSIGNED TO EXAMINER
Friday, February 13, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 8, 2025USE AMENDMENT FILED
Friday, February 13, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 18, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 18, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

evolve inomax medical therapeutic apparatus delivery instruments patients gases flow meters setting